Observed arrival · 2026-11-21
FDA Brief turns enforcement records into watchlists
A plain-English guide to FDA warning letters and recalls, with alerts for companies, suppliers, competitors, or topics.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Food and drug supply-chain teams tracking FDA actions
- Worth noticing
- The homepage lists 3,813 warning letters and 59 Class I recalls from the last 30 days.
Field notes
The page separates warning letters from Class I recalls and shows company names, dates, risk labels, and short issue summaries. One featured letter concerns Natural Essentials’ OTC manufacturing controls; the excerpt names inadequate investigations of failing results, missing component identity tests, and an FDA response review it found inadequate. The homepage figures are site-reported and are not independently verified here.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
⊠LoginAccess appeared gated
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
One card from the complete issue